Kaleido Biosciences, Inc.
KLDO
$0.002
$0.00191,900.00%
OTC PK
| 12/31/2021 | 09/30/2021 | 06/30/2021 | 03/31/2021 | 12/31/2020 | |
|---|---|---|---|---|---|
| Net Income | -90.29M | -90.03M | -90.08M | -85.11M | -81.62M |
| Total Depreciation and Amortization | 2.36M | 2.32M | 2.17M | 2.03M | 1.82M |
| Total Amortization of Deferred Charges | 705.00K | 787.00K | 789.00K | 706.00K | 696.00K |
| Total Other Non-Cash Items | 10.39M | 11.59M | 14.00M | 14.55M | 13.03M |
| Change in Net Operating Assets | -263.00K | 4.11M | 1.30M | 227.00K | 4.55M |
| Cash from Operations | -77.09M | -71.23M | -71.82M | -67.59M | -61.52M |
| Capital Expenditure | -1.13M | -1.36M | -2.39M | -2.98M | -4.02M |
| Sale of Property, Plant, and Equipment | 438.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -691.00K | -1.36M | -2.39M | -2.98M | -4.02M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | 0.00 | -23.00K | -46.00K | -68.00K |
| Issuance of Common Stock | 70.40M | 74.12M | 75.57M | 109.32M | 40.55M |
| Repurchase of Common Stock | -339.00K | -309.00K | -290.00K | -186.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -20.00K | -99.00K | -99.00K | -79.00K | -79.00K |
| Cash from Financing | 70.04M | 73.71M | 75.16M | 109.00M | 40.40M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -7.75M | 1.13M | 947.00K | 38.43M | -25.14M |